OneMedNet announces next phase of commercial launch with RWD Platform

OneMedNet (ONMD) Corporation announced the next phase of commercial launch with its RWD Platform powered by Palantir Foundry. Following the November 10, 2025, demonstration of live feeds, subscription access, and AI-driven search at major tradeshows, the Company is actively converting customer evaluations into commercial subscriptions. Early results highlight superior performance, speed and analytical depth, reinforcing OneMedNet’s position for life sciences and healthcare organizations generating real-world evidence. This launch drives rapid expansion of subscription contracts, including multi-year deals representing millions in incremental recurring revenue, with adoption growing across life sciences, AI Health Innovators. As the OneMedNet iRWD network scales-with over 2,130 healthcare sites and expanding multimodal data-subscription value rises through greater scale, diversity, real-time access, depth, and insight speed. Customer feedback from evaluations since Fall 2025 confirms the platform’s strengths: unmatched analytical depth across integrated clinical/longitudinal datasets; accelerated cohort feasibility and discovery; streamlined intuitive workflows; and faster onboarding of diverse data partners.